-
41
The risk of plasmodium vivax parasitaemia after plasmodium falciparum infection: A systematic review and meta-analysis
Published 2018Conference item -
42
-
43
-
44
-
45
On the adequacy of a 28 day follow-up period for artemether limefantrine against uncomplicated plasmodium falciparum malaria
Published 2017Conference item -
46
-
47
Economic costs of Plasmodium vivax episodes: a multi-country comparative analysis using primary trial data
Published 2018Conference item -
48
-
49
-
50
-
51
Strong protective effect of Mediterranean type glucose-6-phosphate dehydrogenase deficiency against vivax malaria
Published 2019Conference item -
52
Incidence of Salmonella bacteremia among young children in sub-Saharan Africa: MAL055 RTS, S/AS01 Salmonella Ancillary Study
Published 2017Conference item -
53
Cost-effectiveness of podoconiosis lymphoedema treatment in northern Ethiopia: Results from the goblet trial
Published 2018Conference item -
54
-
55
Cooperation in countering artemisinin resistance in Africa: learning from COVID-19
Published 2022Journal article -
56
-
57
Long-term in vitro culture of Plasmodium vivax isolates from Madagascar maintained in Saimiri boliviensis blood
Published 2017Conference item -
58
-
59
-
60
In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees
Published 2018Conference item